PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIntraperitoneal
Intraperitoneal
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
823 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CarcinomaD002277—C80.0605615130149
Peritoneal neoplasmsD010534——515414134144
NeoplasmsD009369—C803918511172
Neoplasm metastasisD009362EFO_0009708—2134511670
HerniaD006547—K40-K4621—44753
Postoperative painD010149—G89.18156181544
Ventral herniaD006555EFO_1001866K43———22325
Colonic neoplasmsD003110—C186521416
PeritonitisD010538EFO_0008588K653233615
Incisional herniaD000069290—K43.221—11215
Show 34 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ovarian neoplasmsD010051EFO_0003893C56816019—30172
Ovarian epithelial carcinomaD000077216——605119—22136
Stomach neoplasmsD013274EFO_0003897C16386819—21136
Colorectal neoplasmsD015179——293210—1982
Fallopian tube neoplasmsD005185——39257—570
AdenocarcinomaD000230——24226—451
HyperthermiaD000084462——10158—2051
FeverD005334—R50.910148—1747
AscitesD001201—R1815164—636
Pancreatic neoplasmsD010190EFO_0003860C2520121—433
Show 47 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Appendiceal neoplasmsD001063EFO_0003880C18.1812——524
MesotheliomaD008654—C45811——523
Malignant mesotheliomaD000086002——78——216
Lung neoplasmsD008175—C34.90121——214
Esophageal neoplasmsD004938—C1596———13
Breast neoplasmsD001943EFO_0003869C50122———12
Rectal neoplasmsD012004——62——410
Uterine cervical neoplasmsD002583——61——29
SarcomaD012509——61——28
Tissue adhesionsD000267——14——37
Show 34 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Wounds and injuriesD014947—T14.82———35
Biliary tract neoplasmsD001661—C24.93———14
Bile duct neoplasmsD001650——4————4
Gallbladder neoplasmsD005706EFO_0004606C232———13
Urinary bladder neoplasmsD001749—C671———23
Head and neck neoplasmsD006258——3————3
Local anesthesiaD000772——1———12
Retroperitoneal neoplasmsD012186——1———12
Squamous cell carcinomaD002294——2————2
RhabdomyosarcomaD012208——2————2
Show 39 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative complicationsD011183——————66
PneumoperitoneumD011027——————55
InflammationD007249MP_0001845—————44
Inguinal herniaD006552HP_0000023K40————44
Acalculous cholecystitisD042101EFO_1000790—————33
Peritoneal diseasesD010532EFO_0009541K66.9————33
Internal herniaD000082122——————33
Acute cholecystitisD041881EFO_1001289K81.0————22
PancreatitisD010195EFO_0000278K85————22
FistulaD005402——————22
Show 77 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
4 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use